Zucheng Xie

机构：Chinese Academy of Medical Sciences & Peking Union Medical College · ORCID：0000-0002-7910-9660

发表论文 38 篇 · 总被引 365 次 · h-index 12

代表论文

• Expression of N 6 -methyladenosine (m 6 A) regulators correlates with immune microenvironment characteristics and predicts prognosis in diffuse large cell lymphoma (DLBCL) (2021 · Bioengineered · 被引 27)
• Identification of three small nucleolar RNAs ( snoRNAs ) as potential prognostic markers in diffuse large B‐cell lymphoma (2022 · Cancer Medicine · 被引 15)
• JAK3 A573V and JAK3 M511I mutations in peripheral T-cell lymphoma mediating resistance to anti-PD-1 therapy through the STAT3/PD-L1 pathway (2025 · Journal for ImmunoTherapy of Cancer · 被引 13)
• Efficacy and safety of PD‐1 monoclonal antibody plus rituximab in relapsed/refractory diffuse large B cell lymphoma patients (2023 · European Journal Of Haematology · 被引 9)
• Multi-omics analysis and response prediction of PD-1 monoclonal antibody containing regimens in patients with relapsed/refractory diffuse large B-cell lymphoma (2024 · Cancer Immunology Immunotherapy · 被引 8)
• MYD88L265P and MYD88other variants show different molecular characteristics and prognostic significance in diffuse large B-cell lymphoma (2023 · Journal of Cancer Research and Clinical Oncology · 被引 6)